Related Experiment Video

Updated: Jun 6, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Pediatric pulmonary Hodgkin lymphoma: analysis of 10 years data from a single center

T Urasinski1, E Kamienska, Aleksandra Gawlikowska-Sroka

  • 1Department of General and Clinical Anatomy, Pomeranian Medical University, Szczecin, Poland.

European Journal of Medical Research
|December 15, 2010
PubMed

Insights

Pulmonary involvement in pediatric Hodgkin lymphoma (HL) occurs in about 10% of cases. Early detection of primary pulmonary Hodgkin lymphoma, though rare, is crucial for successful treatment outcomes.

Area of Science:

  • Pediatric Oncology
  • Pulmonary Medicine
  • Hematology

Background:

  • Lungs are a common extralymphatic site for Hodgkin lymphoma (HL) in adults.
  • Limited data exists on pediatric pulmonary HL, necessitating further investigation.

Purpose of the Study:

  • To evaluate the frequency, clinical presentation, and prognostic impact of pulmonary HL in children.
  • To characterize primary pulmonary Hodgkin lymphoma (PPHL) in a pediatric cohort.

Main Methods:

  • Retrospective analysis of pediatric patients diagnosed and treated at a single center over 10 years.
  • Review of clinical data, imaging findings (nodules, infiltrates with cavitations), and treatment outcomes.

Main Results:

  • Pulmonary lesions were identified in 9.4% (3/32) of pediatric HL patients.
  • Two cases presented with concomitant HL, while one had primary pulmonary Hodgkin lymphoma (solitary form).
  • All three patients achieved sustained remission with B-DOPA/MVPP chemotherapy and radiation therapy.

Conclusions:

  • Pulmonary HL affects up to 10% of children with the disease.
  • Primary pulmonary Hodgkin lymphoma is rare and may present as non-resolving pneumonia with cavitary infiltrates.
  • Timely diagnosis and treatment, including chemotherapy and radiation, lead to favorable prognoses in pediatric pulmonary HL.

More Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...